Post-market evaluation of serology-based point of care tests, page-8

  1. 387 Posts.
    lightbulb Created with Sketch. 729
    As I understand these 14 day figures Wondfo would lack sufficient sensitivity 6.2% of the time; Alltest Biotech 9.2% of the time; VivaChek 21.5% of the time and CTK 15.4% of the time.

    So it could be argued that Wondfo is 50% better than Alltest; three and a half times better than Vivachek and two and a half times better than CTK.

    poorinvestor
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $2.977M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 680000 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 300000 1
View Market Depth
Last trade - 16.30pm 14/07/2025 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.